CO6321129A2 - Inhibidor de la cristalizacion y su uso en capsulas de gelatina - Google Patents
Inhibidor de la cristalizacion y su uso en capsulas de gelatinaInfo
- Publication number
- CO6321129A2 CO6321129A2 CO07106971A CO07106971A CO6321129A2 CO 6321129 A2 CO6321129 A2 CO 6321129A2 CO 07106971 A CO07106971 A CO 07106971A CO 07106971 A CO07106971 A CO 07106971A CO 6321129 A2 CO6321129 A2 CO 6321129A2
- Authority
- CO
- Colombia
- Prior art keywords
- crystallization
- inhibitor
- immiscible
- active ingredient
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención describe cápsulas de gelatina blanda que encapsulan un ingrediente activo inmiscible con agua y un excipiente compuesto de un inhibidor de la cristalización que estabiliza el inhibidor inmiscible con agua. El inhibidor de la cristalización es por lo menos un compuesto monoacilglicerol cuyo grupo acilo es un residuo de ácido graso de 6-19 átomos de carbono. El contenido de la cápsula es más resistente a la turbiedad, forma una emulsión gruesa, y la cristalización del ingrediente activo comparada con las composiciones que no tienen el inhibidor de la cristalización.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66482605P | 2005-03-21 | 2005-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6321129A2 true CO6321129A2 (es) | 2011-09-20 |
Family
ID=36675980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO07106971A CO6321129A2 (es) | 2005-03-21 | 2007-10-11 | Inhibidor de la cristalizacion y su uso en capsulas de gelatina |
Country Status (10)
Country | Link |
---|---|
US (1) | US8673351B2 (es) |
EP (1) | EP1885342B8 (es) |
CN (1) | CN101141953A (es) |
CO (1) | CO6321129A2 (es) |
ES (1) | ES2573539T3 (es) |
HU (1) | HUE029192T2 (es) |
IL (1) | IL185729A0 (es) |
MX (1) | MX2007011250A (es) |
PL (1) | PL1885342T3 (es) |
WO (1) | WO2006102157A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009542605A (ja) * | 2006-07-06 | 2009-12-03 | アレス トレーディング ソシエテ アノニム | アニリノ−ピリミジンの経口医薬組成物、その製法、及びその使用 |
US9011908B2 (en) | 2009-04-06 | 2015-04-21 | Banner Life Sciences Llc | Progesterone solutions for increased bioavailability |
CN101721931B (zh) * | 2009-11-26 | 2012-08-08 | 广州普正生物科技有限公司 | 一种多相混悬系统及其制备方法与应用 |
US8900631B2 (en) | 2011-04-28 | 2014-12-02 | Health Science Funding, LLC | Dosage form to increase prasterone bioavailability |
WO2013144976A2 (en) * | 2012-03-28 | 2013-10-03 | Medreich Limited | Chewable soft gelatin capsule dosage form of mucolytic agents |
EP3033085A1 (en) * | 2013-08-14 | 2016-06-22 | ratiopharm GmbH | Dosage form comprising enzalutamide |
EP3881829A1 (en) * | 2014-11-07 | 2021-09-22 | Sublimity Therapeutics Limited | Compositions comprising cyclosporin |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
CA3128939A1 (en) * | 2019-02-06 | 2020-08-13 | Emerald Health Pharmaceuticals Inc. | Formulations of cannabidiol derivatives and their use as modulators of cannabinoid receptor type 2 (cb2) |
WO2020212948A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI65914C (fi) * | 1978-03-07 | 1984-08-10 | Sandoz Ag | Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a |
GB8903804D0 (en) | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
DE3629386A1 (de) * | 1986-08-29 | 1988-03-03 | Scherer Gmbh R P | Gelatinekapseln und verfahren zu ihrer herstellung |
ES2033086T3 (es) * | 1988-01-29 | 1993-03-01 | Sankyo Company Limited | Un procedimiento para la preparacion de una composicion farmaceutica. |
FR2683225B1 (fr) | 1991-10-31 | 1993-12-31 | Gattefosse Sa | Procede pour ameliorer une huile glycerolysee. |
DE4221491C2 (de) * | 1992-06-29 | 1994-09-29 | Pohl Boskamp Gmbh Chem Pharma | Verfahren zur Herstellung von Weichgelatinekapseln |
SI1033128T2 (sl) * | 1993-09-28 | 2012-02-29 | Scherer Gmbh R P | Izdelava mehke Ĺľelatinaste kapsule |
GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
JPH10211425A (ja) * | 1997-01-29 | 1998-08-11 | Fuji Capsule Kk | カプセルの乾燥方法 |
EP1014953B1 (en) * | 1997-03-05 | 2012-04-25 | Sugen, Inc. | Formulations for hydrophobic pharmaceutical agents |
US6063762A (en) * | 1997-12-05 | 2000-05-16 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
ID25908A (id) * | 1998-03-06 | 2000-11-09 | Novartis Ag | Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida |
CA2326485C (en) * | 1998-04-01 | 2008-12-09 | Rtp Pharma Inc. | Anticancer compositions |
JP3500313B2 (ja) * | 1998-10-27 | 2004-02-23 | 花王株式会社 | カプセル粒子の水分除去方法 |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6652880B1 (en) | 1999-04-01 | 2003-11-25 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
US20030235595A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
US20020049157A1 (en) | 1999-08-25 | 2002-04-25 | Jiangping Wu | Use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
DE60104206T2 (de) * | 2000-09-22 | 2005-09-22 | Galephar M/F | Halbfeste arzneizubereitung enthaltend isotretinoin |
US20040022862A1 (en) * | 2000-12-22 | 2004-02-05 | Kipp James E. | Method for preparing small particles |
US20040033257A1 (en) * | 2002-05-30 | 2004-02-19 | Strides Inc. | Pharmaceutical formulation in a drug delivery system and process for preparing the same |
GB2391472B (en) * | 2002-08-02 | 2004-12-08 | Satishchandra Punambhai Patel | Pharmaceutical compositions |
GB2391473B (en) * | 2002-08-02 | 2004-07-07 | Satishchandra Punambhai Patel | Pharmaceutical compositions |
US7025911B2 (en) * | 2002-09-13 | 2006-04-11 | Freund Corporation | Manufacturing method for oral quick-dissolving seamless capsule |
JP2004262774A (ja) * | 2003-02-20 | 2004-09-24 | Freunt Ind Co Ltd | シームレスカプセル |
IL159729A0 (en) * | 2004-01-06 | 2004-06-20 | Doron I Friedman | Non-aqueous composition for oral delivery of insoluble bioactive agents |
US20050220825A1 (en) * | 2004-03-10 | 2005-10-06 | Adrian Funke | Molecular dispersions of drospirenone |
-
2006
- 2006-03-16 WO PCT/US2006/009859 patent/WO2006102157A1/en active Application Filing
- 2006-03-16 MX MX2007011250A patent/MX2007011250A/es not_active Application Discontinuation
- 2006-03-16 US US11/886,500 patent/US8673351B2/en active Active
- 2006-03-16 CN CNA2006800083050A patent/CN101141953A/zh active Pending
- 2006-03-16 ES ES06738862.9T patent/ES2573539T3/es active Active
- 2006-03-16 PL PL06738862.9T patent/PL1885342T3/pl unknown
- 2006-03-16 HU HUE06738862A patent/HUE029192T2/en unknown
- 2006-03-16 EP EP06738862.9A patent/EP1885342B8/en active Active
-
2007
- 2007-09-05 IL IL185729A patent/IL185729A0/en unknown
- 2007-10-11 CO CO07106971A patent/CO6321129A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US8673351B2 (en) | 2014-03-18 |
MX2007011250A (es) | 2007-11-14 |
US20110020438A1 (en) | 2011-01-27 |
EP1885342B1 (en) | 2016-03-09 |
EP1885342B8 (en) | 2016-06-22 |
IL185729A0 (en) | 2008-01-06 |
HUE029192T2 (en) | 2017-02-28 |
WO2006102157A1 (en) | 2006-09-28 |
CN101141953A (zh) | 2008-03-12 |
PL1885342T3 (pl) | 2016-10-31 |
ES2573539T3 (es) | 2016-06-08 |
EP1885342A1 (en) | 2008-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6321129A2 (es) | Inhibidor de la cristalizacion y su uso en capsulas de gelatina | |
ES2646946T3 (es) | Uso de N-alquil-N-acilglucaminas especiales para el acondicionamiento del cabello en agentes para el lavado del cabello | |
AR081364A1 (es) | Composiciones farmaceuticas de pazopanib y metodos para su elaboracion | |
AR097214A1 (es) | Composiciones edulcorantes | |
CO6290641A2 (es) | Preparacion de capsula que contiene los ingredientes farmaceuticamente activos liquidos y solidos, la cual presenta exelentes propiedades de los ingredientes farmaceuticamente activos | |
AR078814A1 (es) | Dentifrico de fluoruro estanoso y citrato de zinc de bajo contenido de agua con una mejor estabilidad, reologia y eficacia | |
EA201792224A1 (ru) | Композиции, содержащие ибрутиниб | |
EA201200096A1 (ru) | Фармацевтическая композиция ингибитора протеазы вируса гепатита c | |
CO6470839A2 (es) | Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas | |
GT200600346A (es) | Nueva fórmula cristalina v de la agomelatina, un proceso para su preparación y composiciones farmacéuticas que la contienen | |
BRPI0502466A (pt) | forma de dosagem sólida para ingrediente ativo lábil a ácidos | |
AR086651A1 (es) | Dentifrico de ion metalico con bajo contenido de agua | |
AR081520A1 (es) | Composicion farmaceutica que comprende una dispersion solida de tacrolimus en un vehiculo | |
CO6640213A2 (es) | Comprimido de desintegración por vía oral que contiene acarbosa | |
UY32704A (es) | Compuestos de 2,3-dihidro-1h-indeno | |
ES2720954T3 (es) | Formulaciones estabilizadas de estatina | |
SI3060203T1 (en) | A effervescent tablet containing a high level of aspirin | |
CR20170142A (es) | Composiciones farmacéuticas resistentes al abuso | |
BRPI1007471A8 (pt) | Composições de enxágue para cuidados pessoais | |
BR112014030680A2 (pt) | forma de dosagem efervescente | |
AR061165A1 (es) | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas | |
BRPI0510694A (pt) | composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole | |
AR088918A1 (es) | Composiciones antitranspirantes anhidras | |
AR072333A1 (es) | Composiciones inyectables a base de taxoides | |
PE20130374A1 (es) | Composicion farmaceutica que comprende ibuprofeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |